MidFlorida Orthopaedic Associates, PLLC
Orthopaedic Surgery
Dr. David C. Lamoreaux, MD
David C. Lamoreaux, MD works in the field of Orthopaedic Surgery. He attended Albany Medical College. He received awards:"CMS Meaningful Use Stage 1 Certification". David C. Lamoreaux, MD is a published doctor as well. He has 1 publication published. The latest was: Translation Step-cut Osteotomy for the Treatment of Posttraumatic Cubitus Varus. David Lamoreaux accepts all Medicare patients.
Publications
Schools
Albany Medical College
Palmetto Health Richland
Shriner39s Hospital For Children
University of Utah
Procedures Preformed
- ACL (Anterior Cruciate Ligament) Surgery
- All Shoulder or Elbow Replacement Procedures
- Ankle Arthroscopy
- Ankle Replacement
- View All
Conditions Treated
- Achilles Tendinitis
- Ankle Fracture
- Ankle Sprain and Achilles Tendon Sprain or Rupture
- Anterior Cruciate Ligament (ACL) or Posterior Cruciate Ligament (PCL) Tear
- View All
Doctors Specialties
- Orthopedic Surgery
- Orthopaedic Surgery
Accepted Insurances
- AARP
- Accepts most major Health Plans. Please contact our office for details.
- Aetna
- AvMed
- Blue Cross Blue Shield of Florida PPO
- CarePlus
- CHAMPVA
- Cigna
- Tricare
- Special Needs Plan SNP
- Preferred Care Partners
- United Healthcare
- Worker's Compensation WC
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Albany Medical College
Hospital
-
Heart of Florida Regional Medical Center
Drug Facts
NPI NUMBER |
|
1992813877 |
NPPES Provider LastName |
|
LAMOREAUX |
NPPES Provider FirstName |
|
DAVID |
NPPES Provider ZIPCode |
|
338376821 |
NPPES Provider State |
|
FL |
Specialty Description |
|
Orthopedic Surgery |
Total Claim Count |
|
631.0 |
Distinct Opioid Count |
|
4.0 |
Opioid Claim Count |
|
206.0 |
Percent Opioid Claims |
|
32.65 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1992813877 |
Last Name Of The Provider |
LAMOREAUX |
First Name Of The Provider |
DAVID |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog